Skip to main content
SpringerLink
Log in

Assay Procedures for Compound Testing of hiPSC-Derived Cardiomyocytes Using Multiwell Microelectrode Arrays

  • Protocol
  • First Online:
Book cover Cell-Based Assays Using iPSCs for Drug Development and Testing

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1994))

Abstract

The cardiac action potential requires a precise timing of activation and inactivation of ion channel subtypes. Deviations, for example, due to blockage of specific voltage-gated potassium channels, can result in live-threatening arrhythmias. Due to the limitations of standard cellular assays based on cells which artificially express only single ion channel subtypes, many potentially interesting compounds are discarded during drug development. More predictive functional assays are required. With the upcoming of human stem-cell derived cardiomyocytes (hiPS-CM) these assays are available, supporting even the design of patient-derived disease models. Microelectrode array systems allow to noninvasively record and evaluate cardiac field action potentials. In this chapter we describe how to cultivate hiPS-CM on two parallelized MEA systems and suggest an experimental strategy for compound tests.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gintant GA, Su Z, Martin RL, Cox BF (2006) Utility of hERG assays as surrogate markers of delayed cardiac repolarization and QT safety. Toxicol Pathol 34:81–90. https://doi.org/10.1080/01926230500431376

    Article  CAS  PubMed  Google Scholar 

  2. Antzelevitch C (2007) Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace 9(Suppl 4):iv4–i15. https://doi.org/10.1093/europace/eum166

    Article  PubMed  Google Scholar 

  3. Mitcheson JS, Chen J, Lin M et al (2000) A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci U S A 97:12329

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Morissette P, Hreiche R, Turgeon J (2005) Drug-induced long QT syndrome and torsade de pointes. Can J Cardiol 21:857–864

    CAS  PubMed  Google Scholar 

  5. Stett A, Egert U, Guenther E et al (2003) Biological application of microelectrode arrays in drug discovery and basic research. Anal Bioanal Chem 377:486–495. https://doi.org/10.1007/s00216-003-2149-x

    Article  CAS  PubMed  Google Scholar 

  6. Kraushaar U, Buckenmaier S, Guenther E (2009) MEA-based biosensors to study cellular differentiation and integration. Tissue Eng Part A 15:726–726

    Google Scholar 

  7. Kraushaar U, Meyer T, Hess D et al (2011) Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models. Expert Opin Drug Saf:1–14. https://doi.org/10.1517/14740338.2012.639358

    Article  PubMed  Google Scholar 

  8. Halbach M, Egert U, Hescheler J, Banach K (2003) Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem 13:271–284. https://doi.org/10.1159/000074542

    Article  CAS  PubMed  Google Scholar 

  9. Millard D, Dang Q, Shi H et al (2018) Cross-site reliability of human induced pluripotent stem cell derived cardiomyocyte based safety assays using microelectrode arrays: results from a blinded CiPA pilot study. Toxicol Sci 164(2):550–562. https://doi.org/10.1093/toxsci/kfy110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mulder P, de Korte T, Dragicevic E et al (2018) Predicting cardiac safety using human induced pluripotent stem cell-derived cardiomyocytes combined with multi-electrode array (MEA) technology: a conference report. J Pharmacol Toxicol Methods 91:36–42. https://doi.org/10.1016/j.vascn.2018.01.003

    Article  CAS  PubMed  Google Scholar 

  11. Nyquest H (1928) Certain topics in telegraph transmission theory. Transact Am Inst Electr Eng 47:617–644

    Article  Google Scholar 

  12. Holt GR, Koch C (1999) Electrical interactions via the extracellular potential near cell bodies. J Comput Neurosci 6:169–184. https://doi.org/10.1023/A:1008832702585

    Article  CAS  PubMed  Google Scholar 

  13. Buzsáki G, Anastassiou CA, Koch C (2012) The origin of extracellular fields and currents—EEG, ECoG, LFP and spikes. Nat Rev Neurosci 13:407–420. https://doi.org/10.1038/nrn3241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bowlby MR, Peri R, Zhang H, Dunlop J (2008) hERG (KCNH2 or Kv11.1) K+ channels: screening for cardiac arrhythmia risk. Curr Drug Metab 9:965–970

    Article  CAS  PubMed  Google Scholar 

  15. Joshi A, Dimino T, Vohra Y et al (2004) Preclinical strategies to assess QT liability and torsadogenic potential of new drugs: the role of experimental models. J Electrocardiol 37(Suppl):7–14

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under (grant no. 115439), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies. This publication reflects only the author’s views, and neither the IMI JU nor EFPIA nor the European Commission is liable for any use that may be made of the information contained therein.

Author information

Authors and Affiliations

  1. Department of Electrophysiology, NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany

    Udo Kraushaar

  2. AIT Austrian Institute of Technology GmbH, Vienna, Austria

    Elke Guenther

Authors
  1. Udo Kraushaar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elke Guenther
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Udo Kraushaar .

Editor information

Editors and Affiliations

  1. Division of Biotechnology, Department of Physics, Chemistry and Biology (IFM), Linköping University, Linköping, Sweden

    Carl-Fredrik Mandenius

  2. Tissue Injury and Repair Group, University of Edinburgh, Edinburgh, UK

    James A. Ross

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Kraushaar, U., Guenther, E. (2019). Assay Procedures for Compound Testing of hiPSC-Derived Cardiomyocytes Using Multiwell Microelectrode Arrays. In: Mandenius, CF., Ross, J. (eds) Cell-Based Assays Using iPSCs for Drug Development and Testing. Methods in Molecular Biology, vol 1994. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9477-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9477-9_18

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9476-2

  • Online ISBN: 978-1-4939-9477-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation